financetom
Business
financetom
/
Business
/
Altisource Portfolio Solutions Q1 Adjusted Loss Narrows, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Altisource Portfolio Solutions Q1 Adjusted Loss Narrows, Revenue Rises
Apr 25, 2024 11:43 AM

02:21 PM EDT, 04/25/2024 (MT Newswires) -- Altisource Portfolio Solutions ( ASPS ) reported a Q1 adjusted loss Thursday of $0.20 per diluted share, compared with a loss of $0.38 per share a year earlier.

One analyst polled by Capital IQ expected a per-share loss of $0.26.

Revenue for the quarter ended March 31 was $39.47 million, up from with $39.46 million a year earlier.

Two analysts surveyed by Capital IQ expected $35 million.

The company's shares were up 11.5% in recent trading.

Price: 1.90, Change: +0.20, Percent Change: +11.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oceaneering International Names Benjamin Laura as Chief Operating Officer
Oceaneering International Names Benjamin Laura as Chief Operating Officer
Nov 21, 2024
05:15 PM EST, 11/21/2024 (MT Newswires) -- Oceaneering International ( OII ) said late Thursday it has appointed Benjamin Laura as chief operating officer, effective Jan. 1. Laura currently serves as the company's chief innovation officer. ...
Amneal Pharmaceuticals Gets FDA Nod for Diabetes Injections, Resubmits Application for Migraine Treatment
Amneal Pharmaceuticals Gets FDA Nod for Diabetes Injections, Resubmits Application for Migraine Treatment
Nov 21, 2024
05:16 PM EST, 11/21/2024 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) late Thursday said US regulators have approved its exenatide formulation as an adjunct treatment to help control glucose levels in the bloodstream of adults with type 2 diabetes mellitus. The company plans to market pen injectors filled with the synthetic generic peptide in either 1.2-mililiter or 2.4-mililiter quantities....
Warner Music Files Mixed Shelf Registration
Warner Music Files Mixed Shelf Registration
Nov 21, 2024
05:15 PM EST, 11/21/2024 (MT Newswires) -- Warner Music Group ( WMG ) filed a registration statement with the US Securities and Exchange Commission late Thursday covering the potential sale of several securities from time to time. The prospectus covers class A common stock, preferred stock, debt securities, warrants, rights, purchase contracts and units. The company said it plans to...
BRIEF-Regentis Biomaterials Ltd Files To Withdraw U.S. IPO Plans - SEC Filing
BRIEF-Regentis Biomaterials Ltd Files To Withdraw U.S. IPO Plans - SEC Filing
Nov 21, 2024
Nov 21 (Reuters) - Regentis Biomaterials Ltd : * REGENTIS BIOMATERIALS LTD FILES TO WITHDRAW U.S. IPO PLANS - SEC FILING * REGENTIS BIOMATERIALS LTD SAYS IT HAD FILED FOR U.S. IPO IN NOVEMBER 2022 Source text: [https://tinyurl.com/yjz3d5jh] Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved